These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1101733)

  • 1. The origin and fate of osteoclasts.
    Hall BK
    Anat Rec; 1975 Sep; 183(1):1-11. PubMed ID: 1101733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms by which cells of the osteoblast lineage control osteoclast formation and activity.
    Martin TJ; Ng KW
    J Cell Biochem; 1994 Nov; 56(3):357-66. PubMed ID: 7876329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteocytes subjected to fluid flow inhibit osteoclast formation and bone resorption.
    Tan SD; de Vries TJ; Kuijpers-Jagtman AM; Semeins CM; Everts V; Klein-Nulend J
    Bone; 2007 Nov; 41(5):745-51. PubMed ID: 17855178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoblast and osteoclast precursors in primary cultures of calvarial bone cells.
    Burger EH; Boonekamp PM; Nijweide PJ
    Anat Rec; 1986 Jan; 214(1):32-40. PubMed ID: 3954057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New knowledge on the origin, function and fate of osteoclasts.
    Bonucci E
    Clin Orthop Relat Res; 1981; (158):252-69. PubMed ID: 6268344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoclast-osteoblast communication.
    Matsuo K; Irie N
    Arch Biochem Biophys; 2008 May; 473(2):201-9. PubMed ID: 18406338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of CSF-1 in bone and bone marrow development.
    Cecchini MG; Hofstetter W; Halasy J; Wetterwald A; Felix R
    Mol Reprod Dev; 1997 Jan; 46(1):75-83; discussion 83-4. PubMed ID: 8981367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation.
    Lee SH; Rho J; Jeong D; Sul JY; Kim T; Kim N; Kang JS; Miyamoto T; Suda T; Lee SK; Pignolo RJ; Koczon-Jaremko B; Lorenzo J; Choi Y
    Nat Med; 2006 Dec; 12(12):1403-9. PubMed ID: 17128270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of cathepsin K accelerates the resorption cycle and osteoblast differentiation in vitro.
    Morko J; Kiviranta R; Mulari MT; Ivaska KK; Väänänen HK; Vuorio E; Laitala-Leinonen T
    Bone; 2009 Apr; 44(4):717-28. PubMed ID: 19118660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity.
    Kanatani M; Sugimoto T; Kano J; Kanzawa M; Chihara K
    J Cell Physiol; 2003 Jul; 196(1):180-9. PubMed ID: 12767054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of low-level laser therapy on proliferation and differentiation of murine bone marrow cells into osteoblasts and osteoclasts.
    Bouvet-Gerbettaz S; Merigo E; Rocca JP; Carle GF; Rochet N
    Lasers Surg Med; 2009 Apr; 41(4):291-7. PubMed ID: 19347941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Everolimus suppresses cancellous bone loss, bone resorption, and cathepsin K expression by osteoclasts.
    Kneissel M; Luong-Nguyen NH; Baptist M; Cortesi R; Zumstein-Mecker S; Kossida S; O'Reilly T; Lane H; Susa M
    Bone; 2004 Nov; 35(5):1144-56. PubMed ID: 15542040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoblast and osteoclast cell number and cell activity in postmenopausal osteoporosis.
    Gruber HE; Ivey JL; Thompson ER; Chesnut CH; Baylink DJ
    Miner Electrolyte Metab; 1986; 12(4):246-54. PubMed ID: 3762511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The origin of the osteoclast.
    Hanaoka H
    Clin Orthop Relat Res; 1979; (145):252-63. PubMed ID: 394900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cadmium on osteoclast formation and activity in vitro.
    Wilson AK; Cerny EA; Smith BD; Wagh A; Bhattacharyya MH
    Toxicol Appl Pharmacol; 1996 Oct; 140(2):451-60. PubMed ID: 8887463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of bone cell function by RANKL and OPG in different in vitro models.
    Lin JM; Callon KE; Lin CQ; Bava U; Zheng MH; Reid IR; Cornish J
    Eur J Clin Invest; 2007 May; 37(5):407-15. PubMed ID: 17461987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cellular basis of bone resorption.
    Chambers TJ
    Clin Orthop Relat Res; 1980 Sep; (151):283-93. PubMed ID: 7418318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrical callus formation and its osteogenesis.
    Ohashi T
    Nihon Seikeigeka Gakkai Zasshi; 1982 Jul; 56(7):615-33. PubMed ID: 7175296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of osteoclast differentiation and bone resorption by a novel lysophosphatidylcholine derivative, SCOH.
    Kwak HB; Lee SW; Li YJ; Kim YA; Han SY; Jhon GJ; Kim HH; Lee ZH
    Biochem Pharmacol; 2004 Apr; 67(7):1239-48. PubMed ID: 15013839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of electromagnetic stimulation on the functional responsiveness of isolated rat osteoclasts.
    Shankar VS; Simon BJ; Bax CM; Pazianas M; Moonga BS; Adebanjo OA; Zaidi M
    J Cell Physiol; 1998 Sep; 176(3):537-44. PubMed ID: 9699506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.